Vanston David Cecil 4
4 · VOLITIONRX LTD · Filed Dec 23, 2020
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Vanston David Cecil
Chief Financial Officer
Transactions
- Gift
Stock Option (Right to Buy)
2020-12-22−50,000→ 0 totalExercise: $3.25From: 2020-02-11Exp: 2025-02-11→ Common Stock (50,000 underlying) - Gift
Stock Option (Right to Buy)
2020-12-22+50,000→ 50,000 total(indirect: By Daughter)Exercise: $3.25From: 2020-02-11Exp: 2025-02-11→ Common Stock (50,000 underlying) - Gift
Stock Option (Right to Buy)
2020-12-22+60,000→ 60,000 total(indirect: By Daughter)Exercise: $4.00From: 2019-01-23Exp: 2024-01-23→ Common Stock (60,000 underlying) - Gift
Stock Option (Right to Buy)
2020-12-22−60,000→ 0 totalExercise: $4.00From: 2019-01-23Exp: 2024-01-23→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]The option to purchase an aggregate of 60,000 shares of Common Stock of VolitionRx Limited (the "Issuer"), was granted to Mr. Vanston on January 23, 2018, under the Issuer's 2015 Stock Incentive Plan (the "2015 Plan"). The option was transferred as a gift by Mr. Vanston to his daughter on December 22, 2020. Mr. Vanston disclaims beneficial ownership of the shares held by his daughter.
- [F2]The option to purchase an aggregate of 50,000 shares of Common Stock of the Issuer was granted to Mr. Vanston on February 11, 2019 under the Issuer's 2015 Plan. The option was transferred as a gift by Mr. Vanston to his daughter on December 22, 2020. Mr. Vanston disclaims beneficial ownership of the shares held by his daughter.